Hikma Pharmaceuticals PLC
HKMPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $359 | $190 | $188 | $421 |
| Dep. & Amort. | $197 | $190 | $182 | $169 |
| Deferred Tax | $0 | $0 | $76 | $99 |
| Stock-Based Comp. | $27 | $25 | $22 | $29 |
| Change in WC | -$213 | -$8 | -$98 | -$128 |
| Other Non-Cash | $194 | $211 | $160 | $48 |
| Operating Cash Flow | $564 | $608 | $530 | $638 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$165 | -$169 | -$138 | -$145 |
| Net Acquisitions | -$150 | -$105 | -$380 | -$17 |
| Inv. Purchases | $0 | -$27 | -$15 | -$3 |
| Inv. Sales/Matur. | $0 | $1 | $395 | $6 |
| Other Inv. Act. | -$66 | -$33 | -$469 | -$79 |
| Investing Cash Flow | -$381 | -$333 | -$607 | -$238 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $124 | -$73 | $430 | -$83 |
| Stock Issued | -$38 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$300 | $0 |
| Dividends Paid | -$175 | -$137 | -$125 | -$120 |
| Other Fin. Act. | -$100 | -$127 | -$63 | -$84 |
| Financing Cash Flow | -$188 | -$337 | -$58 | -$287 |
| Forex Effect | -$12 | -$3 | -$21 | -$10 |
| Net Chg. in Cash | -$17 | -$65 | -$156 | $103 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $205 | $270 | $426 | $323 |
| End Cash | $188 | $205 | $270 | $426 |
| Free Cash Flow | $399 | $439 | $392 | $493 |